Prognostic factors for progression-free and overall survival in advanced biliary tract cancer-Reference-Cited by-同舟云学术

Prognostic factors for progression-free and overall survival in advanced biliary tract cancer

Published:2016-01 Issue:1 Volume:27 Page:134-140
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bridgewater J.,Lopes A.,Wasan H.,Malka D.,Jensen L.,Okusaka T.,Knox J.,Wagner D.,Cunningham D.,Shannon J.,Goldstein D.,Moehler M.,Bekaii-Saab T.,McNamara M.G.,Valle J.W.

Funder

UCL Clinical Trials Unit

Lilly Oncology

Eli Lilly Japan

Australasian Gastro Intestinal Trials Group

Eli Lilly and Amgen

Ministry of Health, Labour, and Welfare, Health Labour Sciences Research Grant

UCLH/UCL Biomedical Research Centre

CRUK

UCL CRUK

Cancer Research UK

Eli Lilly

and

Amgen

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/1/134/16701865/mdv483.pdf

Reference28 articles.

1. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States;Patel;Hepatology,2001

2. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010

3. Predictors of survival in patients with advanced biliary tract cancer: results from the UK ABC-02 randomized phase III trial;Wasan;Gastrointestinal Cancers Symposium, Miami,2010

4. Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan;Miyakawa;J Hepatobiliary Pancreat Surg,2009

5. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer;McNamara;Eur J Cancer,2014

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current state of radiomics in hepatobiliary and pancreatic malignancies;Artificial Intelligence Surgery;2023-11-28

2. Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence;2023-10-12

3. Prognostic role of the controlling nutritional status (CONUT) score in patients with biliary tract cancer: a meta-analysis;Annals of Medicine;2023-09-26

4. Pan‐cancer efficacy and safety of anlotinib plus PD‐1 inhibitor in refractory solid tumor: A single‐arm, open‐label, phase II trial;International Journal of Cancer;2023-05-08

5. Efficacy and safety comparison of neoadjuvant chemotherapy followed by surgery and upfront surgery for treating intrahepatic cholangiocarcinoma: a systematic review and meta-analysis;BMC Gastroenterology;2023-04-12